Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mahamaya LifesciencesBOM:544611 -1.06%16 PS Ratio is 2.46 as of Aug. 15, 2026, which is 118% above its 10-year median of 1.13. GuruFocus rates BOM:544611 with a GF Score™ of 16/100. The stock has 4 warning signs investors should review. Among 244 Agriculture companies, Mahamaya Lifesciences ranks worse than 79.51% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Mahamaya Lifesciences's share price is ₹186.00.
Mahamaya Lifesciences's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹75.64. Hence, Mahamaya Lifesciences's PS Ratio for today is 2.46.
Good Sign:
Mahamaya Lifesciences Ltd stock PS Ratio (=1.02) is close to 1-year low of 0.96.
The historical rank and industry rank for Mahamaya Lifesciences's PS Ratio or its related term are showing as below:
BOM:544611'
s PS Ratio Range Over the Past 10 Years
Min: 0.96 Med: 1.13 Max: 2.5
Current: 2.47
During the past 5 years, Mahamaya Lifesciences's highest PS Ratio was 2.50. The lowest was 0.96. And the median was 1.13.
BOM:544611's PS Ratio is ranked worse than 79.51% of 244
companies
in the Agriculture industry
Industry Median: 0.965
vs BOM:544611: 2.47
During the past 5 years, Mahamaya Lifesciences's highest 3-Year average Revenue per Share Growth Rate was 43.20% per year. The lowest was 41.50% per year. And the median was 42.35% per year.
Mahamaya Lifesciences (BOM:544611) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Agricultural Inputs subindustry, Mahamaya Lifesciences's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mahamaya Lifesciences PS Ratio vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Mahamaya Lifesciences's PS Ratio distribution charts can be found below:
* The bar in red indicates where Mahamaya Lifesciences's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Mahamaya Lifesciences's Share Price of today is ₹186.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Mahamaya Lifesciences's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹75.64.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Mahamaya Lifesciences (BOM:544611) has a PS Ratio of 2.46 as of Aug. 15, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Mahamaya Lifesciences and its competitors. This is 118% above median its historical median of 1.13. Over the past decade, Mahamaya Lifesciences' PS Ratio has ranged from 0.96 to 2.50. According to the industry distribution chart, Mahamaya Lifesciences ranks #194 out of 244 companies in the Agriculture industry, placing it in the top 79.5%.
Is Mahamaya Lifesciences' PS Ratio too high?
Mahamaya Lifesciences' current PS Ratio of 2.46 is 118% above median its 10-year median of 1.13. Over the past 10 years, this metric has ranged from a low of 0.96 to a high of 2.50. The Agriculture industry median PS Ratio is 0.97. Mahamaya Lifesciences' value of 2.46 is 154.9% above this industry median. Based on the distribution chart, Mahamaya Lifesciences ranks #194 out of 244 companies in the Agriculture industry, which is in the bottom quartile relative to peers. Overall, Mahamaya Lifesciences has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Mahamaya Lifesciences' PS Ratio compare to CTVA and CF?
According to the Agriculture industry distribution chart, Mahamaya Lifesciences ranks #194 out of 244 companies for PS Ratio. This places Mahamaya Lifesciences in the lower half of its industry. The industry median PS Ratio is 0.97. Mahamaya Lifesciences' value of 2.46 is 154.9% above this benchmark. Historically, Mahamaya Lifesciences' own PS Ratio has ranged from 0.96 to 2.50 over the past decade. While the company's 10-year median is 1.13 vs. the industry median of 0.97, Mahamaya Lifesciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for an Agriculture company?
The median PS Ratio among Agriculture companies is 0.97, based on 244 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mahamaya Lifesciences's current PS Ratio of 2.46 is 154.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Mahamaya Lifesciences and its competitors. For the Agriculture industry, the median PS Ratio is 0.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mahamaya Lifesciences's current PS Ratio is 2.46, which is 118% above median its own 10-year median of 1.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mahamaya Lifesciences stock overvalued right now?
Mahamaya Lifesciences (BOM:544611) has a current PS Ratio of 2.46. The current PS Ratio is 2.46, which is 118% above median its 10-year median of 1.13 and 154.9% above the Agriculture industry median of 0.97. Mahamaya Lifesciences' overall GF Score™ is 16/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Mahamaya Lifesciences (BOM:544611), the current PS Ratio is 2.46 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Mahamaya Lifesciences Ltd specializes in the manufacturing of pesticide formulations and supplies bulk formulations catering to both Indian agrochemical companies as well as multinational corporations (MNCs). The company's offerings include Insecticides, Herbicides, and Fungicides. Geographically, it serves multiple Indian states including Punjab, Haryana, Rajasthan, and Uttar Pradesh, and internationally serves countries like the Dominican Republic, Turkey, Egypt, and the UAE. The company generates revenue from the sale of its pesticide formulations.
16GF Score
Get the complete analysis for BOM:544611
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544611 has been successfully added to your 
